» Articles » PMID: 24582311

Recommendations for Live Viral and Bacterial Vaccines in Immunodeficient Patients and Their Close Contacts

Abstract

The present uncertainty of which live viral or bacterial vaccines can be given to immunodeficient patients and the growing neglect of societal adherence to routine immunizations has prompted the Medical Advisory Committee of the Immune Deficiency Foundation to issue recommendations based on published literature and the collective experience of the committee members. These recommendations address the concern for immunodeficient patients acquiring infections from healthy subjects who have not been immunized or who are shedding live vaccine-derived viral or bacterial organisms. Such transmission of infectious agents can occur within the hospital, clinic, or home or at any public gathering. Collectively, we define this type of transmission as close-contact spread of infectious disease that is particularly relevant in patients with impaired immunity who might have an infection when exposed to subjects carrying vaccine-preventable infectious diseases or who have recently received a live vaccine. Immunodeficient patients who have received therapeutic hematopoietic stem transplantation are also at risk during the time when immune reconstitution is incomplete or while they are receiving immunosuppressive agents to prevent or treat graft-versus-host disease. This review recommends the general education of what is known about vaccine-preventable or vaccine-derived diseases being spread to immunodeficient patients at risk for close-contact spread of infection and describes the relative risks for a child with severe immunodeficiency. The review also recommends a balance between the need to protect vulnerable subjects and their social needs to integrate into society, attend school, and benefit from peer education.

Citing Articles

Equine common variable immunodeficiency: lessons from 100 clinical cases.

Julia M, Felippe B Equine Vet Educ. 2024; 36(10):543-554.

PMID: 39555145 PMC: 11565712. DOI: 10.1111/eve.13948.


Invasions of Host-Associated Microbiome Networks.

Murall C, Abbate J, Touzel M, Allen-Vercoe E, Alizon S, Froissart R Adv Ecol Res. 2024; 57:201-281.

PMID: 39404686 PMC: 7616576. DOI: 10.1016/bs.aecr.2016.11.002.


Comparison of Post-Vaccination Cellular Immune Response in Patients with Common Variable Immune Deficiency.

Kostinova A, Latysheva E, Kostinov M, Akhmatova N, Skhodova S, Vlasenko A Vaccines (Basel). 2024; 12(8).

PMID: 39203969 PMC: 11360582. DOI: 10.3390/vaccines12080843.


Cutaneous granulomas associated with rubella virus: A clinical review.

Zhang D, Wanat K, Perelygina L, Rosenbach M, Haun P, Drolet B J Am Acad Dermatol. 2023; 90(1):111-121.

PMID: 37271455 PMC: 11887995. DOI: 10.1016/j.jaad.2023.05.058.


Clinical and biochemical footprints of inherited metabolic diseases. XII. Immunological defects.

de Boer L, Cambi A, Verhagen L, de Haas P, van Karnebeek C, Blau N Mol Genet Metab. 2023; 139(1):107582.

PMID: 37087816 PMC: 10182388. DOI: 10.1016/j.ymgme.2023.107582.


References
1.
MacLennan C, Dunn G, Huissoon A, Kumararatne D, Martin J, OLeary P . Failure to clear persistent vaccine-derived neurovirulent poliovirus infection in an immunodeficient man. Lancet. 2004; 363(9420):1509-13. DOI: 10.1016/S0140-6736(04)16150-3. View

2.
Wilfert C, Buckley R, Mohanakumar T, Griffith J, Katz S, Whisnant J . Persistent and fatal central-nervous-system ECHOvirus infections in patients with agammaglobulinemia. N Engl J Med. 1977; 296(26):1485-9. DOI: 10.1056/NEJM197706302962601. View

3.
Bakare N, Menschik D, Tiernan R, Hua W, Martin D . Severe combined immunodeficiency (SCID) and rotavirus vaccination: reports to the Vaccine Adverse Events Reporting System (VAERS). Vaccine. 2010; 28(40):6609-12. DOI: 10.1016/j.vaccine.2010.07.039. View

4.
Lindegren M, Kobrynski L, Rasmussen S, Moore C, Grosse S, Vanderford M . Applying public health strategies to primary immunodeficiency diseases: a potential approach to genetic disorders. MMWR Recomm Rep. 2004; 53(RR-1):1-29. View

5.
Baxter R, Bartlett J, Rowhani-Rahbar A, Fireman B, Klein N . Effectiveness of pertussis vaccines for adolescents and adults: case-control study. BMJ. 2013; 347:f4249. DOI: 10.1136/bmj.f4249. View